Correction to: Comparison of the Efficacy and Safety of Bilastine 20 mg versus Fexofenadine 180 mg for Treatment of Perennial Allergic Rhinitis: Randomized Controlled Study.

Indian J Otolaryngol Head Neck Surg

Department of Biochemistry, Teerthanker Mahaveer Medical College and Research Centre, Moradabad, Uttar Pradesh India.

Published: December 2024

The text references a correction to a previously published article.
The article in question is identified by its Digital Object Identifier (DOI): 10.1007/s12070-024-04770-0.
This correction suggests that there may have been errors or updates in the original content that need to be addressed for accuracy.

[This corrects the article DOI: 10.1007/s12070-024-04770-0.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569278	PMC
http://dx.doi.org/10.1007/s12070-024-05010-1	DOI Listing

Publication Analysis

correction comparison

comparison efficacy

efficacy safety

safety bilastine

bilastine versus

versus fexofenadine

fexofenadine 180

180 treatment

treatment perennial

perennial allergic

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!